Tumor treating fields (TTFields), a biophysical therapy technology that uses alternating electric fields to inhibit tumor proliferation, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of newly diagnosed or recurrent glioblastomas (GBM) and malignant pleural mesotheliomas (MPM). Clinical trials have confirmed that TTFields are effective in slowing the tumor growth and prolonging patient survival. In recent years, many researchers have found that TTFields can induce anti-tumor immune responses, and their main mechanisms include upregulating the infiltration ratio and function of immune cells, inducing the immunogenic cell death of tumor cells, modulating immune-related signaling pathways, and upregulating the expression of immune checkpoints. Treatment regimens combining TTFields with tumor immunotherapy are emerging as a promising therapeutic approach in clinical practice. Given the increasing number of recently published studies on this topic, we provide an updated review of the mechanisms and clinical implications of TTFields in inducing anti-tumor immune responses. This review not only has important reference value for an in-depth study of the anticancer mechanism of TTFields but also provides insights into the future clinical application of TTFields.
Breast cancer stands as one of the most prevalent and challenging malignancies, necessitating innovative therapeutic approaches. Tumor Treating Fields (TTFields) have emerged as a promising non-invasive avenue in breast cancer therapy. The effectiveness of TTFields largely hinges on the electric field distribution within tumor tissues, which is influenced by various tumor characteristics including location, size, and morphology. However, a significant research gap exists in the TTFields-induced electric field distribution for breast cancer therapy. This study introduces an accessible TTFields transducer placement method tailored for breast cancer treatment, employing finite element analysis to investigate the impact of different tumor attributes on the induced field distribution. Our findings indicate significant effects of tumor characteristics on the induced electric field distribution, highlighting the critical need for personalized transducer placement optimization. This research offers valuable insights and broadens the application prospects of TTFields in breast cancer treatment.